Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Holding ADAP?
Track your performance easily
Adaptimmune Therapeutics (ADAP) Ownership Overview
48.57% Insiders
0.10% Mutual Funds
6.74% Other Institutional Investors
0.23% ETFs
44.35% Public Companies and
Individual Investors
The ownership structure of Adaptimmune Therapeutics (ADAP) stock is a mix of institutional, retail, and individual investors. Approximately 7.08% of the company’s stock is owned by Institutional Investors, 48.57% is owned by Insiders, and 44.35% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $2282758 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 102,478,668 | Insider | 40.07% | 79,523,446 | |
| 38,974,185 | Institution | 15.24% | 30,243,968 | |
| 19,500,000 | Insider | 7.62% | 15,132,000 | |
| 2,343,695 | Institution | 0.92% | 1,818,707 | |
| 1,800,000 | Insider | 0.70% | 1,396,800 | |
| 393,206 | Institution | 0.15% | 305,128 | |
| 161,545 | Institution | 0.06% | 125,359 | |
| 139,801 | Institution | 0.05% | 108,486 | |
| 130,764 | Insider | 0.05% | 101,473 | |
| 99,822 | Institution | 0.04% | 77,462 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 139,801 | Institution | 0.05% | 108,486 | |
| 99,822 | Institution | 0.04% | 77,462 | |
| 16,257 | Institution | <0.01% | 12,615 | |
| 7,944 | Institution | <0.01% | 6,165 | |
| 554 | Institution | <0.01% | 430 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 246,307 | Institution | 0.10% | 203,819 | |
| 161,545 | Institution | 0.06% | 134,082 | |
| 146,899 | Institution | 0.06% | 121,559 | |
| 34,809 | Institution | 0.01% | 28,804 | |
| 6 | Institution | <0.01% | 5 |
FAQ
Who Owns Adaptimmune Therapeutics (ADAP)?
According to the latest TipRanks data, approximately 6.74% of the company's stock is held by institutional investors, 48.57% is held by insiders, and 44.35% is held by retail investors.
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.74% of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors.
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.35% of Adaptimmune Therapeutics (ADAP) stock is held by retail investors.
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
David Mott owns the most shares of Adaptimmune Therapeutics (ADAP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.